In a recent study, Xu et al. reported that reduced expression levels of GAS5 in papillary thyroid carcinoma decreased tumor cell growth, migration, and lymph node metastasis of cancer cells via the IFNγ/STAT1 signaling pathway [71]. The gene discussed is GAS5; the disease is neoplasm.